bpc-157 human clinical trials status fda warning Approval 2026: bpc-157 fda warning news FDA
Description
Abstract Introduction Peptides occupy a strategic position between small molecules and biologics, offering high target specificity, favourable safety profiles, and chemical tractability
however, it is not widely available and requires validation in patients with hepatic, renal, and hematological comorbidities
Andrew: Really
The trouble is that the IFA test is not entirely reliable, it has a very low sensitivity and misses many that do have PA
